RecallDepth
Class II Terminated

Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 68382-256-01) and b) 500 tablets (NDC 68382-256-05) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534

This recall has been terminated (originally issued October 11, 2023).

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
September 21, 2023
Posted
October 11, 2023
Recall Number
D-0038-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7,248 bottles
Firm Location
Pennington, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications

Distribution

Nationwide in the USA.

Lot / Code Info

Lot#: M300652 and M300651, exp. Dec 2024

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls